Literature DB >> 15577264

[Biological significance of lipid hydroperoxide and its reducing enzyme, phospholipid hydroperoxide glutathione peroxidase, in mammalian cells].

Hirotaka Imai1.   

Abstract

Excessive production of reactive oxygen species (ROS) may lead to oxidative stress, loss of cell function, and cell death by apoptosis or necrosis. Recently, ROS have gained attention as important second messengers. ROS lifetimes can be very short, and many types of ROS cannot penetrate organelle membranes. It is therefore thought that only ROS signal molecules that are generated locally in an organelle are transduced when cells are stimulated. Lipid hydroperoxides are one type of ROS of which the biological function has not yet been clarified. The phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) is a unique antioxidant enzyme and separately distributed to the mitochondria, nucleus, nucleoli, and cytosol, where it regulates phospholipid hydroperoxide and fatty acid hydroperoxide as signal molecules. This review focuses on the structure and biological functions of PHGPx in mammalian cells. Overexpression of different types of PHGPx in the RBL2H3 cell line provides a useful model system with which to clarify the ability of different types of PHGPx to modulate cellular function and the importance of lipid hydroperoxides as signal molecules. Transformant studies show that lipid hydroperoxide is an activator of lipoxygenase and cyclooxygenase and participates in inflammation, cardiolipin hydroperoxide is the signal molecule for the release of cytochrome c during apoptotic cell death, and PHGPx is a signal regulator in the IgE receptor-mediated signaling pathway. It is becoming clear that PHGPx has an important role in spermatogenesis, sperm function, and embryonic development, and its deficiency is implicated in human infertility and in embryonic lethality of PHGPx knockout mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577264     DOI: 10.1248/yakushi.124.937

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  5 in total

1.  Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy.

Authors:  Lalage A Katunga; Preeti Gudimella; Jimmy T Efird; Scott Abernathy; Taylor A Mattox; Cherese Beatty; Timothy M Darden; Kathleen A Thayne; Hazaim Alwair; Alan P Kypson; Jitka A Virag; Ethan J Anderson
Journal:  Mol Metab       Date:  2015-04-21       Impact factor: 7.422

Review 2.  Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.

Authors:  Minru Liao; Rui Qin; Wei Huang; Hong-Ping Zhu; Fu Peng; Bo Han; Bo Liu
Journal:  J Hematol Oncol       Date:  2022-04-12       Impact factor: 17.388

3.  The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.

Authors:  Najiao Hong; Yongjun Lin; Zhirong Ye; Chunbaixue Yang; Yulong Huang; Qi Duan; Sixin Xie
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

4.  Redox homeostasis: The Golden Mean of healthy living.

Authors:  Fulvio Ursini; Matilde Maiorino; Henry Jay Forman
Journal:  Redox Biol       Date:  2016-01-19       Impact factor: 11.799

5.  NO Represses the Oxygenation of Arachidonoyl PE by 15LOX/PEBP1: Mechanism and Role in Ferroptosis.

Authors:  Karolina Mikulska-Ruminska; Tamil S Anthonymuthu; Anastasia Levkina; Indira H Shrivastava; Alexandr A Kapralov; Hülya Bayır; Valerian E Kagan; Ivet Bahar
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.